Engineering microbes and metabolic pathways for the production of ethylene glycol

US9994876B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9994876-B2
Application numberUS-201514864493-A
CountryUS
Kind codeB2
Filing dateSep 24, 2015
Priority dateFeb 23, 2012
Publication dateJun 12, 2018
Grant dateJun 12, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to recombinant cells and their use in the production of ethylene glycol.

First claim

Opening claim text (preview).

What is claimed is: 1. A bacterial cell engineered to produce glycolaldehyde from xylose, wherein the cell has reduced or eliminated activity of, or reduced or eliminated expression of, xylulokinase relative to a wild-type cell, the cell has reduced or eliminated activity or reduced or eliminated expression of aldehyde dehydrogenase A relative to a wild-type cell, and the cell recombinantly expresses an enzyme that interconverts xylulose and ribulose. 2. The cell of claim 1 , wherein the enzyme that interconverts xylulose and ribulose is D-tagatose 3-epimerase. 3. The cell of claim 2 , wherein the D-tagatose 3-epimerase is encoded by a dte gene obtained from Pseudomonas cichorii. 4. The cell of claim 1 , wherein the cell further recombinantly expresses D-ribulokinase. 5. The cell of claim 4 , wherein the D-ribulokinase is encoded by a fucK gene obtained from Escherichia coli. 6. The cell of claim 4 , wherein the cell further recombinantly expresses D-ribulose-phosphate aldolase. 7. The cell of claim 6 , wherein the cell further has reduced or eliminated activity or reduced or eliminated expression of L-ribulokinase relative to a wild-type cell. 8. The cell of claim 7 , wherein the cell further recombinantly expresses ATP:L-xylulose 1-phosphotransferase, L-xylulose-1-phosphate aldolase and a glycolaldehyde reductase. 9. The cell of claim 1 , wherein the cell is an Escherichia coli cell. 10. The cell of claim 6 , wherein the D-ribulose-phosphate aldolase is encoded by a fucA gene obtained from Escherichia coli. 11. The cell of claim 6 , wherein the cell is an Escherichia coli cell and the xylulokinase is encoded by a xylB gene. 12. The cell of claim 6 , wherein the cell further recombinantly expresses a glycolaldehyde reductase. 13. The cell of claim 12 , wherein the glycolaldehyde reductase is encoded by a fucO gene obtained from Escherichia coli. 14. The cell of claim 1 , wherein the cell comprises a deletion of a gene encoding aldehyde dehydrogenase A and/or a deletion of a gene encoding xylulokinase. 15. The cell of claim 14 , wherein the cell is an Escherichia coli cell and the aldehyde dehydrogenase A is encoded by an aldA gene and/or the xylulokinase is encoded by a xylB gene. 16. A method of producing ethylene glycol, comprising culturing the cell of claim 1 in the presence of xylose under conditions that result in the production of ethylene glycol. 17. A method of producing glycolaldehyde, comprising culturing the cell of claim 6 in the presence of xylose under conditions that result in the production of glycoaldehyde. 18. An Escherichia coli cell engineered to produce glycolaldehyde, wherein the cell comprises a deletion of a xylB gene and recombinantly expresses a dte gene obtained from Pseudomonas cichorii , a fucK gene obtained from Escherichia coli , and a fucA gene obtained from Escherichia coli. 19. A method of producing glycolaldehyde, comprising culturing the cell of claim 18 in the presence of xylose under conditions that result in the production of glycoaldehyde. 20. An Escherichia coli cell engineered to produce ethylene glycol, wherein the cell comprises a deletion of a xylB gene and an aldA gene, and recombinantly expresses a dte gene obtained from Pseudomonas cichorii , a fucK gene obtained from Escherichia coli , a fucA gene obtained from Escherichia coli , and a fucO gene obtained from Escherichia coli. 21. A method of producing ethylene glycol, comprising culturing the cell of claim 20 in the presence of xylose under conditions that result in the production of ethylene glycol. 22. An engineered bacterial cell that comprises a deletion of a gene encoding xylulokinase and a deletion of a gene encoding aldehyde dehydrogenase A. 23. The cell of claim 22 , wherein the cell is an Escherichia coli cell. 24. The cell of claim 22 that further comprises a gene encoding an enzyme that interconverts xylulose and ribulose. 25. The cell of claim 24 , wherein the enzyme that interconverts xylulose and ribulose is D-tagatose 3-epimerase. 26. The cell of claim 25 , wherein the cell is an Escherichia coli cell.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9994876B2 cover?
The invention relates to recombinant cells and their use in the production of ethylene glycol.
Who is the assignee on this patent?
Massachusetts Inst Technology
What technology area does this patent fall under?
Primary CPC classification C12P7/18. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).